Global Search

Search articles, concepts, and chapters

Ahmadieh Hamid

4 articles in GJC

4 articles in GJC

1.

Structural alterations in the retina and choroid of keratoconus patients detected by optical coherence tomography: A systematic review and meta-analysis.

Bayat Kia, Pooyan Parisa, Feizi Sepehr, Ahmadieh Hamid, Hafezi Farhad, Pourhoseingholi Mohamad Amin et al.

Surv OphthalmolNov 20251 citationsSystematic Review

This meta-analysis found keratoconus patients have significant retinal thinning, RNFL loss, and increased choroidal thickness. OCT can detect these posterior segment changes, suggesting KC is not solely a corneal disease.

2.

Pharmacological agents for treatment of proliferative vitreoretinopathy: A systematic review and network meta-analysis.

Khosravi Mirzaei Sina, Hatami Firouze, Safi Sare, Khorrami Zahra, Khosravi Shadmani Fatemeh, Moshtaghion Seyed Mohamadmehdi et al.

Surv OphthalmolMar 20253 citationsSystematic Review

This review found most drugs don't improve PVR outcomes after RD surgery, but 13-cis-retinoic acid significantly increased reattachment and reduced reoperations, suggesting a potential adjunctive treatment.

3.

Retinal structural alterations in patients with epilepsy taking antiepileptic drugs: A systematic review and meta-analysis of OCT findings.

Bayat Kia, Pooyan Parisa, Looha Mehdi Azizmohammad, Namakin Kosar, Carey Andrew R, Fernando Arevalo J et al.

Surv OphthalmolJan 20255 citationsSystematic Review

This meta-analysis found epilepsy patients on AEDs show significant retinal nerve fiber layer and ganglion cell complex thinning, suggesting OCT can detect drug-induced retinal toxicity.

4.

Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.

Ahmadieh Hamid, Feghhi Mostafa, Tabatabaei Homa, Shoeibi Nasser, Ramezani Alireza, Mohebbi Mohammad Reza

OphthalmologyNov 2008112 citationsRandomized Controlled Trial

This study found adjunctive triamcinolone acetonide in silicone-filled eyes did not significantly improve retinal reattachment or other outcomes for proliferative vitreoretinopathy, suggesting it offers no clinical benefit.

All 4 articles loaded